Excelsior Medical Co., Ltd. (TPE: 4104)
Taiwan
· Delayed Price · Currency is TWD 87.10
-0.40 (-0.46%)
Sep 10, 2024, 1:02 PM CST
Excelsior Medical Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 9, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 14,199 | 13,757 | 10,019 | 8,130 | 7,918 | 6,907 | Upgrade
|
| Market Cap Growth | -5.32% | 37.31% | 23.23% | 2.67% | 14.64% | 17.17% | Upgrade
|
| Enterprise Value | 14,621 | 14,022 | 9,593 | 6,612 | 7,442 | 7,335 | Upgrade
|
| Last Close Price | 86.90 | 80.81 | 56.74 | 43.59 | 39.93 | 36.25 | Upgrade
|
| PE Ratio | 18.32 | 17.75 | 13.95 | 11.81 | 11.44 | 10.52 | Upgrade
|
| PS Ratio | 1.69 | 1.67 | 1.39 | 1.24 | 1.19 | 1.07 | Upgrade
|
| PB Ratio | 1.64 | 1.26 | 0.97 | 0.83 | 0.83 | 0.80 | Upgrade
|
| P/FCF Ratio | 27.08 | -713.88 | 21.52 | 10.42 | 9.44 | 6.04 | Upgrade
|
| P/OCF Ratio | 21.27 | 128.44 | 15.72 | 8.60 | 9.11 | 5.78 | Upgrade
|
| EV/Sales Ratio | 1.74 | 1.70 | 1.33 | 1.01 | 1.11 | 1.14 | Upgrade
|
| EV/EBITDA Ratio | 10.99 | 16.19 | 12.94 | 9.21 | 12.08 | 13.48 | Upgrade
|
| EV/EBIT Ratio | 13.75 | 19.95 | 15.81 | 11.11 | 14.07 | 15.81 | Upgrade
|
| EV/FCF Ratio | 27.88 | -727.65 | 20.61 | 8.47 | 8.87 | 6.42 | Upgrade
|
| Debt / Equity Ratio | 0.14 | 0.13 | 0.08 | 0.08 | 0.07 | 0.17 | Upgrade
|
| Debt / EBITDA Ratio | 1.56 | 1.49 | 0.98 | 0.96 | 1.03 | 2.35 | Upgrade
|
| Debt / FCF Ratio | 2.85 | -74.84 | 1.74 | 0.98 | 0.85 | 1.28 | Upgrade
|
| Asset Turnover | 0.49 | 0.48 | 0.46 | 0.45 | 0.48 | 0.47 | Upgrade
|
| Inventory Turnover | 5.90 | 5.45 | 5.48 | 5.90 | 6.30 | 5.61 | Upgrade
|
| Quick Ratio | 1.36 | 1.38 | 1.44 | 1.66 | 1.86 | 1.59 | Upgrade
|
| Current Ratio | 1.59 | 1.60 | 1.66 | 1.88 | 2.11 | 1.78 | Upgrade
|
| Return on Equity (ROE) | 8.88% | 8.70% | 7.84% | 7.47% | 7.35% | 7.33% | Upgrade
|
| Return on Assets (ROA) | 2.49% | 2.54% | 2.40% | 2.56% | 2.38% | 2.09% | Upgrade
|
| Return on Capital (ROIC) | 3.66% | 3.74% | 3.51% | 3.58% | 3.24% | 2.97% | Upgrade
|
| Earnings Yield | 5.46% | 5.43% | 6.66% | 7.47% | 7.22% | 7.45% | Upgrade
|
| FCF Yield | 3.69% | -0.14% | 4.65% | 9.60% | 10.59% | 16.55% | Upgrade
|
| Dividend Yield | 4.17% | 4.48% | 5.83% | 6.94% | 7.57% | 7.87% | Upgrade
|
| Payout Ratio | 145.68% | 72.45% | 74.02% | 81.37% | 81.48% | 74.69% | Upgrade
|
| Buyback Yield / Dilution | 0.03% | 0.07% | 0.05% | -0.34% | -9.73% | -0.00% | Upgrade
|
| Total Shareholder Return | 4.20% | 4.55% | 5.89% | 6.59% | -2.16% | 7.86% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.